NateMercer
Nate Mercer covers the pharmaceutical industry for Pipeline Briefing, with a focus on corporate governance and litigation. He studied journalism at the University of Oregon and is based in San Francisco.
Articles by Nate Mercer
Companies/September 29
Why is AbbVie considered a controversial drugmaker?
Drug Pipeline/September 24
What is the generic drug price-fixing scandal?
Companies/September 7
Why is Mallinckrodt considered one of the most controversial drug companies?
Investigations/August 28
What is Acthar Gel and what is it used for?
Drug Pipeline/August 25
What is the ATTR-CM market and who competes in it?
Investigations/August 20
What are Vyndamax and Vyndaqel, and what do they treat?
Companies/August 18
Why is Pfizer considered one of the most controversial drug companies in the US?
Companies/August 8
How much did Humira's price rise?
Drug Pipeline/August 3
How did the alleged conspiracy work?
Companies/July 16